Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Preguntas más frecuentes / Tipos de Cáncer / Cáncer de Seno / Cáncer de Seno
Ultima Vez Modificado: 13 de noviembre del 2005
![]()
Dear OncoLink "Ask The Experts,"
I am looking for treatment options for women who have had breast cancer, had a mastectomy, radiation, and chemo, only to find two years later that a cancerous tumor has appeared in the other breast. My aunt is the patient, and I know she tested negative for carrying the cancer gene. Her mother died at a similar age as she is now from breast cancer. I am looking for as much information as possible on treatment options. Most articles do not talk about recurrence within two years and spreading to the other breast.
Carolyn Vachani RN, MSN, AOCN, OncoLink's Medical Correspondent, responds:
Unfortunately, despite all your aunt has gone through, breast cancer can reoccur, and does so in as many as 30% of patients (depending on the extent of their original tumor). Most recurrences occur within 2 years of the original diagnosis, but can also happen many years after therapy.
There are 2 ways this can happen:
a recurrence of the original tumor, which can be local (in the same area as the original tumor), in nearby lymph nodes, or in other organs or bones (distant metastases).
a new primary tumor, which is a second breast cancer that is unrelated to the first (typically in the opposite breast, and so, purely speaking, not a true recurrence, per se).
As you might expect, having one tumor does put you at risk for a second tumor. Treatment with tamoxifen after surgery, radiation, and/or chemotherapy in patients with hormone receptor- positive tumors (ER+/PR+) has been shown to decrease not only the risk of recurrence but also the risk of cancer in the opposite breast (contralateral breast). Tamoxifen has also resulted in improved overall survival. However, it is not an option for everyone, and so the risks and benefits should be discussed with your doctor.
Once detected, treatment options are based on whether it is a local recurrence, a second cancer, or a distant metastasis. Local recurrences or second cancers can often be treated similarly to the original cancer, with surgery and possible radiation , chemotherapy , or hormonal therapy . It can be, in a sense, like starting all over again. If it has been less than six months since chemo, the physician may choose a different type of chemotherapy, but if the treatment was some time ago, the same medications may still be effective.
As for distant metastases, these are not treated with surgery. If we can see tumor cells in one organ, we can assume there are some other cancer cells floating elsewhere in the body that have not grown enough to be detected on a scan. In order to have the best chance of catching these elusive cells, we need to give chemotherapy or hormonal therapy, since it can reach all areas of the body, unlike radiation or surgery. In addition, Herceptin can be an option for patients whose tumors are Her2-Neu positive (a marker determined by the pathologist), no matter what type of recurrence they have.
Dr. Glatstein shares some of the important lessons he has conveyed upon the many oncology professionals he has trained. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

